(Q48575371)

12 February 2018

title

Neuropeptide Y and leptin in patients with obstructive sleep apnea syndrome: role of obesity. (English)

1 reference

12 February 2018

main subject

obesity

0 references

patient

0 references

obstructive sleep apnea

1 reference

2

1 reference

12 February 2018

author name string

Antonia Barceló

1

1 reference

12 February 2018

Elena Llompart

3

1 reference

12 February 2018

Mónica de la Peña

4

1 reference

12 February 2018

Joaquin Durán-Cantolla

5

1 reference

12 February 2018

Antoni Ladaria

6

1 reference

12 February 2018

Margalida Bosch

7

1 reference

12 February 2018

Lourdes Guerra

8

1 reference

12 February 2018

Alvar G N Agustí

9

1 reference

12 February 2018

language of work or name

English

0 references

publication date

29 October 2004

1 reference

12 February 2018

American Journal of Respiratory and Critical Care Medicine

published in

1 reference

12 February 2018

volume

171

1 reference

12 February 2018

issue

2

1 reference

12 February 2018

page(s)

183-187

1 reference

12 February 2018

Pathogenesis of obstructive sleep apnoea/hypopnoea syndrome

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-579OC

A waist is a terrible thing to mind: central obesity, the metabolic syndrome, and sleep apnea hypopnea syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-579OC

Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-579OC

Plasma leptin levels and cardiac sympathetic function in patients with obstructive sleep apnoea-hypopnoea syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-579OC

Obesity and the hypothalamus: novel peptides for new pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-579OC

State-of-the-art-lecture: Obesity-induced hypertension: new concepts from the emerging biology of obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-579OC

Obesity hypertension: role of leptin and sympathetic nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-579OC

The occurrence of sleep-disordered breathing among middle-aged adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-579OC

Obstructive sleep apnoea syndrome in morbidly obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-579OC

Central cardiovascular action of neuropeptide Y in conscious rabbits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-579OC

Pathophysiological role of leptin in obesity-related hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-579OC

Leptin and the regulation of body weight in mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-579OC

Overexpression of the obese (ob) gene in adipose tissue of human obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-579OC

Serum leptin and vascular risk factors in obstructive sleep apnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-579OC

Augmented resting sympathetic activity in awake patients with obstructive sleep apnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-579OC

Effects of obesity on C-reactive protein level and metabolic disturbances in male patients with obstructive sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-579OC

Does the number of hypopnoeas influence therapy in patients with obstructive sleep apnoea?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-579OC

Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-579OC

Neuropeptide Y: a novel angiogenic factor from the sympathetic nerves and endothelium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-579OC

Pharmacology of neuropeptide Y receptor antagonists. Focus on cardiovascular functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-579OC

The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-579OC

Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-579OC

Body fat distribution, serum leptin, and cardiovascular risk factors in men with obstructive sleep apnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-579OC

Influence of treatment on leptin levels in patients with obstructive sleep apnoea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200405-579OC

10.1164/RCCM.200405-579OC

21 January 2018

Identifiers

DOI

1 reference

12 February 2018

PubMed ID

15516536

1 reference

12 February 2018